Works by Harada, Guilherme

Results: 13

Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors.

Published in:

Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf017

By:

Nykaza, Ian;
Murciano-Goroff, Yonina R;
Desilets, Antoine;
Harada, Guilherme;
Postow, Michael A;
Callahan, Margaret K;
Lee, Chung-Han;
Rudin, Charles M;
Kelsen, David Paul;
Stadler, Zsofia K;
Wibmer, Andreas G;
Hechtman, Jaclyn F;
Drilon, Alexander;
Friedman, Claire F

Publication type:

Article

Exacerbated Renal and Hematologic Toxicities to Ifosfamide and Doxorubicin-Based Chemotherapy in a Patient with Retroperitoneal Liposarcoma Harboring a Germline Mutation in the WRN Gene.

Published in:

2022

By:

Awni, Beatriz Mendes;
Holanda Lopes, Carlos Diego;
Harada, Guilherme;
Salgues, Alessandra Corte Real;
França, Gilmar de Andrade;
Testagrossa, Leonardo de Abreu;
Queiroz, Marcelo Araujo;
Gonçalves e Silva, Adriano;
Ferreira, Fabio de Oliveira;
Munhoz, Rodrigo Ramella

Publication type:

Case Study

Successful osimertinib rechallenge following drug-induced pneumonitis after previous anti-PDL1 exposure.

Published in:

Ecancermedicalscience, 2019, v. 13, n. 962-995, p. 1, doi. 10.3332/ecancer.2019.970

By:

Harada, Guilherme;
Costa Santini, Fernando;
Nogueira Amorim Canedo, Felipe Sales;
de Carvalho Oliveira, Leandro Jonata;
Bortot Zuppani, Henrique;
De Castro Jr., Gilberto

Publication type:

Article

The importance of molecular characterization in lung cancer.

Published in:

Brazilian Journal of Pulmonology / Jornal Brasileiro de Pneumologia, 2019, v. 45, n. 3, p. 1, doi. 10.1590/1806-3713/e20190139

By:

de Castro Junior, Gilberto;
Harada, Guilherme;
de Mello, Evandro Sobroza

Publication type:

Article

U.S. Food and Drug Administration anticancer drug approval trends from 2016 to 2018 for lung, colorectal, breast, and prostate cancer.

Published in:

2020

By:

Ribeiro, Tatiane Bomfim;
Ribeiro, Adalton;
Rodrigues, Luíza de Oliveira;
Harada, Guilherme;
Nobre, Moacyr Roberto Cuce

Publication type:

journal article

Phase I study of lurbinectedin in combination with weekly paclitaxel with or without bevacizumab in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2022, v. 40, n. 6, p. 1263, doi. 10.1007/s10637-022-01281-z

By:

Calvo, Emiliano;
Sessa, Cristiana;
Harada, Guilherme;
de Miguel, Maria;
Kahatt, Carmen;
Luepke-Estefan, Xarles Erik;
Siguero, Mariano;
Fernandez-Teruel, Carlos;
Cullell-Young, Martin;
Stathis, Anastasios;
Drilon, Alexander

Publication type:

Article

Dramatic Response to Pembrolizumab Monotherapy in a Patient With ARID1A-Mutant Lung Adenocarcinoma: Case Report.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 5, p. e708, doi. 10.1016/j.cllc.2021.01.011

By:

Harada, Guilherme;
Amano, Mariane Tami;
Antonacio, Fernanda Frozoni;
Behar, Marina Henkin;
Nabuco-de-Araujo, Pedro Henrique Xavier;
Buchpiguel, Carlos Alberto;
Junior, Gilberto de Castro

Publication type:

Article

Eficácia e toxicidade da quimioterapia adjuvante em pacientes com câncer de pulmão de células não pequenas.

Published in:

Brazilian Journal of Pulmonology / Jornal Brasileiro de Pneumologia, 2021, v. 47, n. 3, p. 1, doi. 10.36416/1806-3756/e20200378

By:

Harada, Guilherme;
Vicentini Neffa, Maria Fernanda Batistuzzo;
Colombo Bonadio, Renata;
Zambrano Mendoza, Elizabeth;
Caparica, Rafael;
Leone Lauricella, Letićia;
Yae Takagaki, Teresa;
Rosa Roitberg, Felipe Santa;
Mingarini Terra, Ricardo;
De Castro Jr, Gilberto

Publication type:

Article

Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 601, doi. 10.1038/s41416-024-02760-1

By:

Roa, Paola;
Foglizzo, Valentina;
Harada, Guilherme;
Repetto, Matteo;
Kulick, Amanda;
de Stanchina, Elisa;
de Marchena, Michelle;
Auwardt, Supipi;
Sayed Ahmed, Shaza;
Bremer, Nicole Virginia;
Yang, Soo-Ryum;
Feng, Yangbo;
Zhou, Chao;
Kong, Norman;
Liang, Ruixia;
Xu, Haipeng;
Zhang, Bin;
Bardelli, Alberto;
Toska, Eneda;
Ventura, Andrea

Publication type:

Article

TRK Inhibitors in Non-Small Cell Lung Cancer.

Published in:

2020

By:

Harada, Guilherme;
Gongora, Aline Bobato Lara;
da Costa, Cesar Martins;
Santini, Fernando Costa

Publication type:

journal article

Immunophenotyping in Myelodysplastic Syndromes Can Add Prognostic Information to Well-Established and New Clinical Scores.

Published in:

PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0081048

By:

Reis-Alves, Suiellen C.;
Traina, Fabíola;
Harada, Guilherme;
Campos, Paula M.;
Saad, Sara T. O.;
Metze, Konradin;
Lorand-Metze, Irene

Publication type:

Article

Author Correction: TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers.

Published in:

2024

By:

Thawani, Rajat;
Repetto, Matteo;
Keddy, Clare;
Nicholson, Katelyn;
Jones, Kristen;
Nusser, Kevin;
Beach, Catherine Z.;
Harada, Guilherme;
Drilon, Alexander;
Davare, Monika A.

Publication type:

Correction Notice

TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers.

Published in:

NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00663-1

By:

Thawani, Rajat;
Repetto, Matteo;
Keddy, Clare;
Nicholson, Katelyn;
Jones, Kristen;
Nusser, Kevin;
Beach, Catherine Z.;
Harada, Guilherme;
Drilon, Alexander;
Davare, Monika A.

Publication type:

Article